Table 1.

Causes of screen failures (February 2011 through April 2017), N = 561

Causen/N%
Failed eligibility criteria 233/561 41 
 Multiple comorbidity 135/233  
 Thrombocytopenia 32/233  
 Neutropenia 3/233  
 Pancytopenia 15/233  
 Relapsed or graft failure 29/233  
 Secondary malignancy 5/233  
 Other 14/233  
Patient was not interested 129/561 23 
Physician was not interested (some received AZA off-study) 84/561 15 
Detectable minimal residual disease after transplant (received AZA off-study) 26/561 
No clinical trial benefit 28/561 
Outside physician refused 10/561 
On competing IND study 10/561 
Causen/N%
Failed eligibility criteria 233/561 41 
 Multiple comorbidity 135/233  
 Thrombocytopenia 32/233  
 Neutropenia 3/233  
 Pancytopenia 15/233  
 Relapsed or graft failure 29/233  
 Secondary malignancy 5/233  
 Other 14/233  
Patient was not interested 129/561 23 
Physician was not interested (some received AZA off-study) 84/561 15 
Detectable minimal residual disease after transplant (received AZA off-study) 26/561 
No clinical trial benefit 28/561 
Outside physician refused 10/561 
On competing IND study 10/561 

AZA, azacitidine; IND, investigational new drug.

Close Modal

or Create an Account

Close Modal
Close Modal